UBS AM’s Alnylam Pharmaceuticals ALNY Stock Holding History

UBS AM’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$224M	Buy	677,519 +25,153	+4%	+$8.56M	0.05%	332
2025 Q4	$259M	Sell	652,366 -56,198	-8%	-$24.9M	0.05%	298
2025 Q3	$323M	Sell	708,564 -249,772	-26%	-$102M	0.07%	253
2025 Q2	$313M	Buy	958,336 +222,225	+30%	+$61.5M	0.06%	283
2025 Q1	$199M	Buy	736,111 +25,513	+4%	+$6.56M	0.05%	363
2024 Q4	$167M	Buy	710,598 +4,367	+0.6%	+$1.15M	0.04%	398
2024 Q3	$194M	Sell	706,231 -129,182	-15%	-$33.6M	0.05%	359
2024 Q2	$203M	Buy	835,413 +76,763	+10%	+$12.1M	0.06%	297
2024 Q1	$113M	Buy	758,650 +17,589	+2%	+$2.93M	0.04%	420
2023 Q4	$142M	Sell	741,061 -33,415	-4%	-$5.69M	0.06%	341
2023 Q3	$137M	Buy	774,476 +100,598	+15%	+$19.2M	0.06%	325
2023 Q2	$135M	Hold	673,878	–	–	0.07%	326
2023 Q1	$135M	Buy	673,878 +15,958	+2%	+$3.35M	0.07%	326
2022 Q4	$156M	Buy	657,920 +54,388	+9%	+$11.6M	0.08%	272
2022 Q3	$121M	Buy	603,532 +10,310	+2%	+$1.97M	0.07%	312
2022 Q2	$86.5M	Sell	593,222 -11,943	-2%	-$1.69M	0.05%	410
2022 Q1	$98.8M	Sell	605,165 -35,545	-6%	-$5.42M	0.04%	440
2021 Q4	$109M	Sell	640,710 -4,862	-0.8%	-$904K	0.04%	444
2021 Q3	$122M	Buy	645,572 +22,344	+4%	+$4.19M	0.05%	371
2021 Q2	$106M	Sell	623,228 -42,301	-6%	-$6.2M	0.05%	419
2021 Q1	$94M	Sell	665,529 -39,906	-6%	-$6.01M	0.04%	439
2020 Q4	$91.7M	Sell	705,435 -17,790	-2%	-$2.38M	0.04%	432
2020 Q3	$105M	Sell	723,225 -114,402	-14%	-$16.3M	0.06%	329
2020 Q2	$124M	Buy	837,627 +6,241	+0.8%	+$841K	0.08%	256
2020 Q1	$90.5M	Buy	831,386 +7,717	+0.9%	+$891K	0.07%	296
2019 Q4	$94.9M	Buy	823,669 +32,360	+4%	+$3.23M	0.06%	340
2019 Q3	$63.6M	Sell	791,309 -173,457	-18%	-$13.7M	0.04%	447
2019 Q2	$70M	Sell	964,766 -193,372	-17%	-$14.8M	0.05%	405
2019 Q1	$108M	Sell	1,158,138 -259,352	-18%	-$21.7M	0.08%	274
2018 Q4	$103M	Buy	1,417,490 +96,532	+7%	+$7.42M	0.09%	247
2018 Q3	$116M	Sell	1,320,958 -37,641	-3%	-$3.79M	0.09%	254
2018 Q2	$134M	Buy	1,358,599 +17,428	+1%	+$1.73M	0.1%	227
2018 Q1	$160M	Sell	1,341,171 -53,042	-4%	-$6.84M	0.13%	188
2017 Q4	$177M	Buy	1,394,213 +29,816	+2%	+$3.75M	0.15%	150
2017 Q3	$160M	Sell	1,364,397 -84,118	-6%	-$7.18M	0.15%	149
2017 Q2	$116M	Sell	1,448,515 -282,566	-16%	-$18.1M	0.11%	214
2017 Q1	$88.7M	Buy	1,731,081 +63,655	+4%	+$2.94M	0.09%	247
2016 Q4	$62.4M	Buy	1,667,426 +148,664	+10%	+$6.22M	0.07%	309
2016 Q3	$103M	Sell	1,518,762 -144,120	-9%	-$10.2M	0.11%	212
2016 Q2	$92.3M	Buy	1,662,882 +10,959	+0.7%	+$690K	0.1%	212
2016 Q1	$104M	Sell	1,651,923 -269,353	-14%	-$17.9M	0.12%	183
2015 Q4	$181M	Buy	1,921,276 +9,741	+0.5%	+$903K	0.21%	104
2015 Q3	$154M	Buy	1,911,535 +96,271	+5%	+$10.7M	0.17%	134
2015 Q2	$218M	Buy	1,815,264 +40,972	+2%	+$4.9M	0.21%	109
2015 Q1	$185M	Buy	1,774,292 +172,538	+11%	+$17.5M	0.18%	130
2014 Q4	$155M	Sell	1,601,754 -123,055	-7%	-$11.4M	0.15%	161
2014 Q3	$135M	Buy	1,724,809 +20,618	+1%	+$1.33M	0.13%	170
2014 Q2	$108M	Buy	1,704,191 +34,330	+2%	+$2.04M	0.11%	217
2014 Q1	$112M	Buy	1,669,861 +83,359	+5%	+$6.45M	0.12%	196
2013 Q4	$102M	Buy	1,586,502 +360,743	+29%	+$21.5M	0.12%	204
2013 Q3	$78.5M	Sell	1,225,759 -120,120	-9%	-$5.99M	0.1%	236
2013 Q2	$41.7M	Buy	+1,345,879	New	+$35.8M	0.05%	361